Medical Management Systems (MMS), the software company behind the UK’s leading online employee health-record product, Meddbase, has secured a £2.25m investment from BOOST&Co.

Having started in a single office in north London more than 20 years ago, Meddbase now operates globally, enabling healthcare professionals to carry out patient-led services securely, using any web-enabled device. The software has processed more than 16 million patient records and, in 2021, holds more than 900 million patient appointments, processing more than £1bn in revenue for its customers.

The investment from BOOST&Co will enable MMS – named as a finalist in the Healthcare Technology Provider of the Year category at the 2021 Health Investor Awards – to continue to develop its practice management and patient record system, as well as expand the online platform’s capability to secure contracts in new geographical markets and verticals.

BOOST&Co has chosen to invest in MMS because of its outstanding product and its track record with reputable customers such as UnitedHealthcare, Bupa and the NHS. It is also anticipated that several development roles will be generated within the business as part of its investment in growth.

Oliver Reece, principal at BOOST&Co, says: “We’re delighted to be able to provide this support for MMS and we’re excited about working with the team during the next stage of the company’s growth. MMS is a great example of how investment can accelerate growth and we are pleased to support the business as it expands internationally and pursues a strategy that is clear and well-thought-through.”

Will Temple, managing director at MMS, says: “Since 2004, we have been pioneering the development of cloud-native systems capable of managing every aspect of medical businesses securely online. Our mission to join up healthcare processes, using our market-leading platform Meddbase, has been built on continuous innovation.

“There is always more work to be done to remain at the forefront of technological advances in healthcare, and this investment will enable us to continue to expand our product range and further grow the business.”


Back to list